Ingemar Ernberg is senior professor of Tumor Biology at Karolinska Institutet (KI)  in Stockholm. Ernberg made his PhD thesis at KI  with George Klein in 1979, finished his MD in 1984, studied abroad in Omaha, Nebraska 1986 and at the MRC Laboratory of Molecular Biology (LMB) in Cambridge UK 1988-1990. He was secretary of science at the Swedish Cancer Society 1983-93. He was the first chair of and built up the new department Microbiology and Tumorbiology Center (MTC) of KI 1993-1999. He is now the chair for the KI  Precision Cancer Medicine (PCM) program anddeputy director of Cancer Center Karolinska (CCK), while he heads his research group at MTC.  He is  running the lecture and course series “What is life? The future of Biology” at Karolinska Institutet since 20 years. He was member of the BoD of Cancer Core Europe (CCE) 2016 – 20 and chairs the CCE task force for education.

Ingemar Ernberg’s work deals with tumor viruses in man, lymphoma biology, transcritional regulation (Epstein-Barr virus), epigenetics (methylation) and tumor cell plasticity. One seminal discovery established that the B-lymphocyte is the site of EBV-latency in vivo (Gratama et al, PNAS, 1988), another one on the regulation of EBV by methylation. More recent interests have dealt with experimental approaches to apply the cell attractor concept in cancer relating to non-genetic variability and tumor cell plasticity.

Publications overview. Total 297 publications; 11 791 (11 278) citations; Highest citation years 2021-2023. 46,24 average citation; h-Index = 56 Co-authored ten books (Popular science, Text books Oncology and Virology, most recent Rethinking Cancer MIT Press 2021; Quantum Biology and Life Singapore 2023).